Loading...
BVMF
DASA3
Market cap721mUSD
Dec 05, Last price  
3.14BRL
1D
-16.27%
1Q
139.69%
Jan 2017
-82.27%
IPO
-46.52%
Name

Diagnosticos da America SA

Chart & Performance

D1W1MN
BVMF:DASA3 chart
P/E
—
P/S
0.26
EPS
—
Div Yield, %
—
Shrs. gr., 5y
30.13%
Rev. gr., 5y
28.55%
Revenues
15.32b
+7.51%
528,280,000670,450,000858,820,0001,137,525,0001,388,313,0001,501,967,0002,179,874,0002,264,142,0002,487,487,0002,697,573,0002,794,399,0003,040,775,0003,399,308,0003,933,451,0004,364,585,0007,039,331,00010,418,674,00013,128,893,00014,252,235,00015,322,079,000
Net income
-1.20b
L+2.83%
10,157,00016,511,00056,621,000-12,980,00084,997,00097,966,000145,255,00085,192,000131,301,00082,289,00023,813,00094,738,000131,443,000184,378,000124,777,000-147,739,000-216,937,000-387,766,000-1,166,016,000-1,198,990,000
CFO
28m
P
107,648,000132,873,000383,383,000338,606,000106,244,000195,293,000-25,643,000315,495,000254,980,000459,222,000494,329,000841,937,000653,235,000530,331,000699,366,000766,504,0001,298,179,0001,339,682,000-963,624,00027,946,000
Dividend
Dec 27, 20220.096871 BRL/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Diagnósticos da América S.A. provides diagnostic test services in Latin America. It offers approximately 3,000 types of examinations of clinical analyses and diagnostic imaging services. The company also provides support services to approximately 5,000 laboratories under the Alvaro brand, as well as operates for the public sector under the CientíficaLab brand. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 17, 2000. The company was founded in 1966 and is based in Barueri, Brazil.
URL
https://www.dasa3.com.br/
IPO date
Nov 19, 2004
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT